Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

Sevabertinib Approved for First-Line Mutated NSCLC

Published Date: 11 Sep 2026

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Knowledge Hub

Oncology

Preventing Chemotherapy-Associated Oral Complications 

Review of evidence-based strategies to prevent and manage chemotherapy-associated oral complications for clinicians.

Oncology

Immune-Checkpoint Therapy Complications in the ICU: Clinical Challenges and Evidence-Based Management 

Comprehensive review of immune-checkpoint therapy complications in the ICU with evidence-based management for healthcare professionals.

Oncology

Pediatric Tumor Ecosystems and Cellular Competition: An Evidence-Based Review 

Comprehensive review of pediatric tumor ecosystems and cellular competition for healthcare professionals.

Oncology

Degraders for Endocrine-Resistant Tumors: Mechanisms, Clinical Applications, and Emerging Therapeutic Strategies 

Comprehensive review of degrader-based therapies for endocrine-resistant tumors in clinical oncology.

Oncology

Coordinated Cancer Survivorship Care: A Comprehensive Review for Healthcare Professionals

Oncology

Robotic Intratumoral Resection for Organ Preservation: Current Evidence and Clinical Implications

Oncology

Exposure Modeling for Bispecific Antibodies: Scientific Foundations and Clinical Implications

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot